[EFFECT] Helix Acquisition Corp. II SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

EFFECT

Rhea-AI Filing Summary

07/11/2025 - 12:15 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 10, 2025 4:15 P.M.

Form:

S-4

CIK:	0001869105
Company Name:	Helix Acquisition Corp. II
File Number:	333-288222

CIK:	0002022953
Company Name:	TheRas, Inc.
File Number:	333-288222-01

Source: View Original Filing on SEC EDGAR

Helix Acqsn II

NASDAQ:HLXB

HLXB Rankings

#5349 Ranked by Market Cap

N/A Ranked by Dividends

HLXB Latest News

Jul 11, 2025

Helix Acquisition Corp. II and BridgeBio Oncology Therapeutics Announce Effectiveness of Registration Statement for Proposed Business Combination

Feb 28, 2025

BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines

Feb 14, 2024

Helix Acquisition Corp. II Announces Closing of $184 Million Initial Public Offering, Including the Full Exercise of the Underwriter';s Option to Purchase Additional Shares

Feb 9, 2024

Helix Acquisition Corp. II Announces Pricing of Upsized $160 Million Initial Public Offering

HLXB Latest SEC Filings

Jul 11, 2025

[8-K] Helix Acquisition Corp. II Reports Material Event

Jun 20, 2025

[S-4] Helix Acquisition Corp. II Business Combination Registration

HLXB Stock Data

Market Cap 251.90M

Float 10.02M

Insiders Ownership 5.82%

Institutions Ownership 86.84%

Short Percent 0.02%

Industry Shell Companies

Sector Pharmaceutical Preparations

Country United States

City BOSTON